US Patent Issued to Convert Pharmaceuticals on Aug. 18 for "Prodrugs and medical uses thereof" (Belgian Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,620, issued on Aug. 18, was assigned to Convert Pharmaceuticals S.A. (Liege, Belgium).

"Prodrugs and medical uses thereof" was invented by Arne Heyerick (Liege, Belgium), Sofie Deschoemaeker (Liege, Belgium), Sophie Thiolloy (Liege, Belgium), Dominique Tersago (Liege, Belgium) and Philippe Lambin (Liege, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to nitrogen mustards bearing substituted piperazine carboxamide and their corresponding pharmaceutically acceptable salts as cytotoxic agents that target tumours and methods of use thereof, alone or in combination with other cancer treatments."

The patent was filed on May ...